About
Dewcell develops technology to produce transfusable platelets using stem cell-derived methods, aiming for large-scale, consistent, and high-quality platelet manufacturing for healthcare applications.
Explore Dewcell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.